Please login to the form below
WHO director-general says urgent support is needed for COVAX facility
Immediate funding support totalling $4.3bn is required
FDA sets 10 December date for Pfizer’s COVID-19 vaccine meeting
Independent experts will discuss EUA submission for mRNA-based vaccine
Lilly links up with Precision BioSciences in genome editing deal
Precision will receive an upfront cash payment of $100m
AZ’s COVID-19 vaccine demonstrates efficacy rate of up to 90%
Across two dosing regimens, vaccine has average efficacy of 70%
UK could approve Pfizer’s COVID-19 vaccine this week
The Telegraph reported the possible timeframe on Sunday
Regeneron’s COVID-19 antibody cocktail scores FDA emergency approval
Drug approved to treat high-risk patients with mild to moderate COVID-19
Lilly’s repurposed COVID-19 med baricitinib bags FDA emergency approval
Drug approved for emergency use in combination with Gilead's remdesivir
Pfizer, BioNTech to submit emergency use request for COVID-19 vaccine to FDA today
Shot could be available for high-risk populations in the US by middle of December
Pierre Fabre’s Braftovi scores NICE backing for BRAF+ colorectal cancer
Drug approved in combination with Merck's KGaA's Erbitux
Q&A: Caroline Gosling
PME interviews Rubica's Director of Culture & Engagement
-
Q&A: Isabel GibsonPME interviews W2O ISO's Managing Director
-
Q&A: Kate Callan
-
FDA delays BMS’ liso-cel decision, citing COVID-19 travel restrictions Inspection of third-party manufacturing plant delayed due to COVID-19
-
Healthineers’ COVID-19 antibody test launches in EUTest can measure levels of neutralising antibodies in the blood
-
UPDATED: BMS completes $13.1bn acquisition of MyoKardia
Acquisition will bolster pipeline with targeted cardiovascular therapies
-
Chief investigator of Oxford Vaccine Group says data could be released before ChristmasAstraZeneca is developing a COVID-19 vaccine with Oxford University
-
AZ’s COVID-19 vaccine proves promising in elderly participants, new data shows Immune responses were similar in younger and older adults
-
Sanofi’s quadrivalent flu vaccine Supemtek scores EU approvalCompany expects first EU launches in 2022/2023 flu season
-
MSD launches antibiotic combo Recarbrio in UK Therapeutic indicated to treat infections caused by Gram-negative bacteria
Latest appointments
-
OPEN Health names Rob Barker chief executive officerBarker succeeds outgoing OPEN Health CEO and co-founder David Rowley
-
Merck’s R&D chief Roger Perlmutter heads for the exit as Dean Li takes the helm Perlmutter is set to join the board of AI drug discovery biotech Insitro
-
90TEN bolsters senior management team Agency establishes new role of head of behavioural science
-
Evoke KYNE promotes Dante DelVecchio to senior VP DelVecchio takes on the role after ten years at Evoke KYNE
-
McCann Health North America appoints Jim Joseph as president Joseph will oversee all North American advertising and promotion agencies in the US and Canada
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Senior Account Manager
-
Competitive
-
Senior Leader
-
Exceptionally competitive salary
-
Medical Editor
-
Competitive
-
Healthcare Account Director
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- Russia submits COVID-19 vaccine to WHO for emergency use listing
- CureVac says its COVID-19 vaccine can be stored at standard refrigerator temperature
- CureVac reveals early data for mRNA-based COVID-19 vaccine candidate
- Send Us a Message
- GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year
- Harness the power of data to map new patient pathways
- What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
- WHO director-general says urgent support is needed for COVAX facility
- FDA sets 10 December date for Pfizer’s COVID-19 vaccine meeting
- Lilly links up with Precision BioSciences in genome editing deal
- Rethinking our approach to infectious disease preparedness
PMHub
OPEN Health
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...
Latest intelligence
- Harness the power of data to map new patient pathways
- Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...
- What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
- ...
- Rethinking our approach to infectious disease preparedness
- The importance of long-term strategic investment to prepare for the next threat that emerges...
Quick links
Infographics
